107
Participants
Start Date
February 8, 2017
Primary Completion Date
March 20, 2019
Study Completion Date
March 20, 2019
TIP
TIP dose regimen
TIP and placebo
TIP and inhaled placebo dose regimen
Placebo
Inhaled placebo dose regimen
Novartis Investigative Site, Brussels
Novartis Investigative Site, Leuven
Novartis Investigative Site, Berlin
Novartis Investigative Site, Milan
Novartis Investigative Site, Monza
Novartis Investigative Site, Pavia
Novartis Investigative Site, Hanover
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Pordenone
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Grenoble
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valladolid
Novartis Investigative Site, Baracaldo - Vizcaya
Novartis Investigative Site, Pisa
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Scafati
Novartis Investigative Site, Nice
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Dundee
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Edinburgh
Novartis Investigative Site, Lancaster
Novartis Investigative Site, Leeds
Novartis Investigative Site, London
Novartis Investigative Site, Newcastle upon Tyne
Novartis Investigative Site, Southampton
Lead Sponsor
Collaborators (1)
Queen's University, Belfast
OTHER
University Hospital, Antwerp
OTHER
University of Milan
OTHER
Fundacion Clinic per a la Recerca Biomédica
OTHER
Erasmus Medical Center
OTHER
Papworth Hospital NHS Foundation Trust
OTHER_GOV
Royal Brompton & Harefield NHS Foundation Trust
OTHER
University of Dundee
OTHER
University of Edinburgh
OTHER
Novartis Pharmaceuticals
INDUSTRY